The Efficacy of Nano-water in Combination with Tamsulosin-Dutasteride for Alleviating Lower Urinary Tract Symptoms in Men with Benign Prostatic Hyperplasia
DOI:
https://doi.org/10.56056/Keywords:
Benign prostatic hypertrophy, Lower urinary tract symptoms, Nano-waterAbstract
Background and Objectives: Symptoms of the Lower urinary tract are common in benign prostatic hyperplasia. This study assessed the effectiveness of Nano-water doubled with tamsulosin-dutasteride in improving these symptoms.
Methods: This double-blind, randomized study was conducted in Sulaimani, Iraq, from February 2016 to November 2022. The study included 193 men with an International Prostatic Symptom Score of 13 or higher, peak urine flow rates of 15 milliliters per second or less, and prostatic volumes between 30 and 80 cubic centimeters. The participants were randomly assigned to two groups. Group A (97 men) received Nano-water with tamsulosin-dutasteride, while Group B (96 men) obtained regular water with the same medication. Assessments at baseline and after three months included the International Prostatic Symptom Score, peak urine flow rate, and residual urine volume.
Results: Group A demonstrated more remarkable results than Group B. The International Prostatic Symptom Score fell to 6.67 in Group A compared to 10.87 in Group B. Peak urine flow rates climbed to 17.48 milliliters per second in Group A versus 15.45 milliliters per second in Group B. Residual urine was less than 50 milliliters in 88 percent of Group A patients compared to 75 percent in Group B. All results were statistically significant.
Conclusions: Nano-water combined with tamsulosin-dutasteride improved lower urinary tract symptoms in men with benign prostate hyperplasia.
Downloads
References
1. Filson CP, Wei JT, Hollingsworth JM. Trends in the medical management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. 2013 Dec 1;82(6):1386-93.
2. Walker A, Doyle S, Posnett J, Hunjan M. Cost‐effectiveness of single‐dose tamsulosin and dutasteride combination therapy compared with tamsulosin monotherapy in patients with benign prostatic hyperplasia in the UK. BJU Int. 2013 Sep;112(5):638-46. doi: 10.1111/j.1464-410X.2012.11659. x. Epub 2013 Jan 28.
3. Gajanan K, Tijare SN. Applications of nanomaterials. Materials Today: Proceedings. 2018 Jan 1;5(1):1093-6.
4. Kage A, Gabbai E. Water-Based Nanotechnology: What if We Could Dope Water NanoBioTechnology: BioInspired Devices and Materials of the Future. 2008:461-73.
5. Ebrahim SA, Azab AE. Biological effects of magnetic water on human and animals. Biomedical Sciences. 2017;3(4):78-85.
6. Sami AK, Amin KH, Kurmanji MT. The Novel Use of Nanotechnology Structured Water Magnalife to Control Blood Glucose Level in Type 2 Diabetic Patients. Diabetes. 2018 Jul 1;67(Supplement_1).
7. Yuping L, Takeki H, Kiichiro T, Noboru N, Zbigniew G, Taichi K, et al. Suppressive effects of natural reduced waters on alloxan-induced apoptosis and type 1 diabetes mellitus. Cytotechnology. 2012;64(3):281-97.
8. Shirahata S, Hamasaki T, Teruya K. Advanced research on the health benefit of reduced water. Trends Food Sci. 2012 Feb 1;23(2):124-31
9. Sami AM, Alshimmre RJ, Alkhalidi IM, Alzaidy OJ. Comparison Between Nanotechnology Structured Water and Tadalafil for the Treatment of Erectile Dysfunction.: PD31-10. Journal of Urology. 2018 Apr 1;199(4): e643-4.
10. Sabrina P, Yazdani G, Ashraf SS, Franchi M, Mashayekhan S, Kiani S, et al. Effect of Physico-Chemical Properties of Nanoparticles on Their Intracellular Uptake. Int J Mol Sci. 2020 Oct 28;21(21):8019.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Alaa Al Krush, Ali Sami, Safaa Almukhtar, Ismael Weas

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)









